Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Nordic Biotechnology Aktiebolag
AB
Active
Org 5563515237
Karlavägen 12, 222 39
Lund
Other human health activities n.e.c.
· NACE 8699
Est. 1989
0 employees
Watchlist
Share
Sweden
/
Companies
/
Other human health activities n.e.c.
/
Nordic Biotechnology Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
150
407
162
127
Staff expenses
—
—
—
—
—
EBITDA
−26
148
379
143
112
Depreciation & amort.
−0
−0
—
—
—
EBIT
−26
148
379
143
112
Net financials
—
—
0
0
−1
Profit before tax
−27
124
284
106
84
Tax
−0
−15
−59
−23
−18
Net profit
−27
109
226
84
66
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
545
716
568
625
658
Equity
344
453
279
363
429
Long-term debt
192
182
0
—
—
Short-term debt
9
58
170
107
48
Total debt
201
240
170
107
48
Financial ratios
5-year trend
EBITDA margin
88.2%
This company
15.8%
Market median
+458% vs market
2021
2025
Equity ratio
65.1%
This company
38.2%
Market median
+70% vs market
2021
2025
Return on equity
15.3%
This company
18.4%
Market median
+17% vs market
2021
2025
Net profit margin
51.7%
This company
8.1%
Market median
+538% vs market
2021
2025
Asset turnover
0.19×
This company
1.12×
Market median
-83% vs market
2021
2025
Debt / equity
0.54×
This company
0.62×
Market median
+13% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Nordic Biotechnology Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
